As biologic therapies for inflammatory diseases continue to be developed and introduced widely around the world, TB screening has become increasingly important. Dr. Kevin Winthrop will engage the audience by describing both existing and emerging biologic immunosuppressive therapies, and optimal screening strategies for patients.